JACOBS ENGINEERING GROUP INC. - 10-Q Summary
Business Context and Reporting Period
This filing is a Quarterly Report on Form 10-Q for Jacobs Engineering Group Inc. for the three-month period ended December 31, 2006. The company provides engineering, construction, and technical services to clients in various industries including oil & gas, chemicals, national government programs, and pharmaceuticals.
Key Financial Metrics
| Metric | Q1 2007 (Ended Dec 31, 2006) | Q1 2006 (Ended Dec 31, 2005) |
|---|---|---|
| Revenues | $2,018.5 million | $1,683.5 million |
| Operating Profit | $94.4 million | $67.4 million |
| Net Earnings | $61.3 million | $43.0 million |
| Diluted EPS | $1.01 | $0.72 |
| Operating Cash Flow | $74.6 million | $30.3 million |
| Cash and Equivalents (End of Period) | $484.5 million | $271.2 million |
| Long-Term Debt | $95.4 million | $77.7 million |
| Working Capital | $855.5 million | $609.0 million |
| Backlog | $10,396.5 million | $8,999.5 million |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 19.9% ($335.1 million) year-over-year. This was driven by a 28.8% increase in Project Services and a 17.6% increase in Construction revenues.
- Profitability: Net earnings rose 42.4% ($18.2 million). Operating margins improved as direct costs of contracts decreased as a percentage of revenue from 87.4% to 86.6%.
- Industry Performance: Significant revenue increases were recorded in Chemicals and Polymers (+43.5%), National Government Programs (+30.3%), and Pharmaceuticals and Biotechnology (+59.9%).
- Cash Flow: Operating cash flow more than doubled to $74.6 million, aided by higher net earnings and improved working capital management.
- Acquisitions: The company utilized $24.0 million in cash for the acquisition of W.H. Linder & Associates, Inc., a firm specializing in upstream oil and gas services.
Outlook, Risks, and Unusual Items
- Stock Split: On January 25, 2007, the Board approved a two-for-one stock split to be distributed on or about March 15, 2007.
- Liquidity: The company maintains strong liquidity with $484.5 million in cash and $194.6 million in available borrowing capacity under a $290.0 million revolving credit facility.
- Contingencies: The company is involved in litigation regarding a waste incineration project in Europe, seeking damages in excess of €40.0 million (approx. $52.7 million). The client has filed a counterclaim. The outcome is uncertain.
- Market Risk: The company is exposed to interest rate and foreign currency fluctuations. It utilizes hedging instruments, including a floating-to-fixed interest rate swap and foreign currency forward contracts, to mitigate these risks.
- Backlog: Total backlog increased 15.5% to $10.4 billion, reflecting significant new awards in pharmaceuticals and oil & gas sectors.
Investor Verification Checklist
- Verify the impact of the pending two-for-one stock split on share count and per-share metrics for future reporting.
- Monitor the resolution of the European waste incineration project litigation and potential counterclaim exposure.
- Assess the sustainability of the 59.9% revenue growth in the Pharmaceuticals and Biotechnology sector.
- Review the utilization of the $290.0 million revolving credit facility, currently at $95.4 million.
- Confirm the integration progress and financial contribution of the W.H. Linder & Associates acquisition.